<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> carry a significant risk of developing <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Endoscopic mucosal resection (EMR) and photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) aim at the radical ablation of the dysplastic area </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We used EMR to resect the macroscopic area of dysplastic mucosa followed by <z:chebi fb="7" ids="53228">PDT</z:chebi> to eliminate <z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">residual disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi> was performed after oral administration of <z:chebi fb="0" ids="17549">5-aminolevulinic acid</z:chebi> (ALA, 40 mg/kg), using fractionated illumination 3 and 6 h later with 630 nm light at 100 J/cm(2) through an endoscopic balloon diffuser </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We report 2 patients who developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> shortly after incomplete endoscopic ablation of Barrett's epithelium </plain></SENT>
<SENT sid="5" pm="."><plain>In a 61-year-old man with HGD in 8-cm Barrett's segment, HGD persisted 3 months after treatment </plain></SENT>
<SENT sid="6" pm="."><plain>The oesophagectomy specimen showed a 2.3-cm pT2N0M0 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in Barrett's </plain></SENT>
<SENT sid="7" pm="."><plain>In a 69-year-old woman with extensive HGD in 5-cm Barrett's, HGD persisted after 3 PDT sessions in 1 year </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> occurred 6 months after treatment </plain></SENT>
<SENT sid="9" pm="."><plain>The oesophagectomy showed a pT1bN0M0 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and extensive multifocal HGD in Barrett's </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The combination of EMR and <z:chebi fb="7" ids="53228">PDT</z:chebi> may be a promising option for local treatment of patients with HGD in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, provided <z:hpo ids='HP_0000001'>all</z:hpo> dysplastic tissue can be removed </plain></SENT>
<SENT sid="11" pm="."><plain>Currently it should be offered only to patients who are willing to participate in a clinical trial with an intensive endoscopic follow-up programme </plain></SENT>
</text></document>